GENEPOC
GenePOC Inc. is a privately owned company, member of Debiopharm Group, that develops accurate and cost-effective molecular solutions to detect pathogen genes. GenePOC has developed a simple and stand-alone system for the prevention and early detection of infectious diseases based on a unique microfluidic technology.
GENEPOC
Industry:
Health Diagnostics Pharmaceutical
Address:
Quebec, Quebec, Canada
Country:
Canada
Website Url:
http://www.genepoc-diagnostics.com
Status:
Active
Contact:
+ 1-418-650-3535
Technology used in webpage:
Google Maps Google Google Maps API Google Cloud WP Engine Google Maps For Work ENom DNS
Similar Organizations
Diversitec
Diversitec is a privately held company.
Isuru
Isuru, Inc. is a privately owned corporation.
NuBiyota
NuBiyota LLC is a privately held company.
Official Site Inspections
http://www.genepoc-diagnostics.com
- Host name: 40.108.185.35.bc.googleusercontent.com
- IP address: 35.185.108.40
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "GenePOC"
Meridian Bioscience Announces Agreement to Acquire Business of …
Apr 30, 2019 Founded in 2007, GenePOC has approximately 100 employees and generated total revenues of less than $1 million in calendar 2018. Meridian has agreed to make a cash …See details»
GenePOC - Crunchbase Company Profile & Funding
GenePOC Inc. is a privately owned company, member of Debiopharm Group, that develops accurate and cost-effective molecular solutions to detect pathogen genes. GenePOC has developed a simple and stand-alone system for the …See details»
GenePOC Company Profile 2024: Valuation, Investors, Acquisition
GenePOC General Information Description. Developer of a molecular diagnostics testing device designed to speed up the diagnostic process. The company's device is a portable instrument …See details»
Meridian Bioscience Announces Agreement to Acquire …
Apr 30, 2019 GenePOC’s revogene TM platform is an excellent fit for our customers and strategy to offer gastrointestinal-focused and other targeted diagnostic solutions to meet the diverse needs of today’s ...See details»
GenePOC, a Subsidiary of Debiopharm Group, Reaches an …
Apr 30, 2019 About GenePOC. Founded in 2007 by Dr. Michel Bergeron, GenePOC is a company that specializes in the development of diagnostic devices which enable the …See details»
GenePOC, a subsidiary of Debiopharm Group, reaches an …
GenePOC’s (Canadian affiliate of Debiopharm) molecular diagnostics business portfolio. This decision was made in response to the need to identify a partner with a solid commercialization …See details»
GenePOC reaches an agreement with Meridian Bioscience for the …
On June 3, 2019, GenePOC, a Debiopharm Group company, concluded the sale of its molecular diagnostics business to Meridian Bioscience. The purchase price for GenePOC’s molecular …See details»
GenePOC, a subsidiary of Debiopharm group, reaches an …
Debiopharm became the major shareholder of GenePOC in July 2016. Over years of collaboration, ongoing clinical development led to a number of achievements including FDA …See details»
Meridian Bioscience to buy GenePOC in $120m deal
Diagnostic testing solutions firm Meridian Bioscience has signed a definitive agreement to acquire Canadian molecular diagnostics maker GenePOC in a deal valued at $120m. GenePOC, which was founded in 2007, is a subsidiary of …See details»
Debiopharm invests double digit millions in the Canadian startup ...
Aug 30, 2016 GenePOC, which has just received CE marking for its first bacteriological test, will start commercialization in Europe this autumn, and Debiopharm will set up a future production …See details»
GenePOC | Technological Leadership and Patient-centric Innovation
Oct 24, 2017 GenePOC’s multifactorial strategy, as it innovates toward global leadership, expands testing menus tailored to specific geographies LONDON, U.K. — October 24, 2017 …See details»
Debiopharm invests double digit millions in the canadian startup ...
GenePOC, which has just received CE marking for its first bacteriological test, will start commercialization in Europe this autumn, and Debiopharm will set up a future production line …See details»
GenePOC launches its GenePOC® CDiff test in Canada - Yole Group
The GenePOC CDiff assay is a qualitative in vitro diagnostic test to detect the toxin B (tcdB) gene of toxigenic C. difficilein stool specimens obtained from patients suspected of having CDI. “ …See details»
Debiopharm Invests Double Digit Millions in the Canadian startup ...
Aug 30, 2016 About GenePOC GenePOC is a company that specializes in the development of rapid diagnostic devices which enable the prevention and detection of infectious diseases.See details»
The GenePOC Platform, a Rational Solution for Extreme Point-of …
May 24, 2016 The GenePOC Platform, a Rational Solution for Extreme Point-of-Care Testing Micromachines (Basel). 2016 May 24;7(6):94. doi: 10.3390/mi7060094. Authors Luc …See details»
GenePOC® launches its GenePOC® CDiff test in Canada
Oct 23, 2018 GenePOC announces the Health Canada approval and launch of its molecular diagnostic test for the detection of Clostridium difficile in Canada Québec, Canada – October …See details»
A profile of the GenePOC Carba C assay for the detection and ...
ABSTRACT. The novel GenePOC/Revogene Carba C assay (GenePOC, Québec, Canada; now Meridian Bioscience, Cincinnati, OH, USA) is a CE-IVD marked, FDA-approved qualitative in …See details»
(PDF) A revolutionary microfluidic stand-alone platform …
Jan 1, 2015 GenePOC Inc. (Québec City, QC, Canada) was established in 2007 to develop and industrialize a microfluidic centripetal platform enabling a rtPCR or RT-rtPCR molecular …See details»
The workflow of a typical GenePOC test. Source: GenePOC.
The GenePOC Diagnostics platform is the culmination of a successful academic-industrial transdisciplinary research program in microfluidics, led by Prof. Michel G. Bergeron of the …See details»